Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002325 · ClinicalTrials.gov registry record · NA
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
NCT00002325: Completed NA study, sponsored by Pfizer.
NCT00002325 is a NA study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002325, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To compare the efficacy of fluconazole versus placebo in preventing the development of active coccidioidomycosis and other systemic fungal infections among HIV-infected patients with CD4 lymphocyte counts \< 250 cells/mm3 who are living in the coccidioidal endemic area.
Interventions
- DRUG Fluconazole
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002325 record still lists
NCT00002325 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Fluconazole is the first listed.
NCT00002325 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002325 about?
NCT00002325 is a clinical study titled "A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common". To compare the efficacy of fluconazole versus placebo in preventing the development of active coccidioidomycosis and other systemic fungal infections among HIV-infected patients with CD4 lymphocyte counts \< 250 cells/mm3 who are living in the coccidioidal endemic area.
What is the current status of trial NCT00002325?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002325?
The interventions under investigation include: Fluconazole (DRUG).
Who is sponsoring clinical trial NCT00002325?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.